Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

Autor: Baeten, Jared M., Palanee-Phillips, Thesla, Brown, Elizabeth R., Schwartz, Katie, Soto-Torres, Lydia E., Govender, Vaneshree, Mgodi, Nyaradzo M., Kiweewa, Flavia Matovu, Nair, Gonasagrie, Mhlanga, Felix, Siva, Samantha, Bekker, Linda-Gail, Jeenarain, Nitesha, Gaffoor, Zakir, Martinson, Francis, Makanani, Bonus, Pather, Arendevi, Naidoo, Logashvari, Husnik, Marla, Richardson, Barbra A., Parikh, Urvi M., Mellors, John W., Marzinke, Mark A., Hendrix, Craig W., van der Straten, Ariane, Ramjee, Gita, Chirenje, Zvavahera M., Nakabiito, Clemensia, Taha, Taha E., Jones, Judith, Mayo, Ashley, Scheckter, Rachel, Berthiaume, Jennifer, Livant, Edward, Jacobson, Cindy, Ndase, Patrick, White, Rhonda, Patterson, Karen, Germuga, Donna, Galaska, Beth, Bunge, Katherine, Singh, Devika, Szydlo, Daniel W., Montgomery, Elizabeth T., Mensch, Barbara S., Torjesen, Kristine, Grossman, Cynthia I., Chakhtoura, Nahida, Nel, Annalene, Rosenberg, Zeda, McGowan, Ian, Hillier, Sharon
Zdroj: Obstetrical and Gynecological Survey; August 2016, Vol. 71 Issue: 8 p466-468, 3p
Abstrakt: (Abstracted from N Engl J Med2016; DOI: 10.1056/NEJMoa1506110)The objective of this study was to examine the efficacy of dapivirine vaginal rings in providing protection against human immunodeficiency virus type 1 (HIV-1). HIV-1 infection incidence is one of the highest in sub-Saharan Africa.
Databáze: Supplemental Index